Active — Not RecruitingNot Applicable

An Idiographic Examination of Treatment Mechanisms in Emotion Regulation Therapy

United States24 participantsStarted 2022-11-16

Plain-language summary

This study is an open trial designed to examine individual changes that occur before, during, and after 12 sessions of Emotion Regulation Therapy (ERT) delivered via telehealth for individuals in New York State who are experiencing elevated worry, rumination, or self-criticism.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Between the ages of 18 and 65 * Fluent in English (and therefore able to provide consent) * Currently living in New York State * Access to at least one device with internet and video-conferencing capabilities * High self-reported worry, rumination, and/or self-criticism * Meet Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition (DSM-5) criteria for at least one, current psychological disorder Exclusion Criteria: * Active suicidal ideation or intent * Substance dependence disorder, schizophrenia, bipolar-I disorder, or a primary DSM-5 diagnosis of borderline or narcissistic personality disorder * Currently in therapy or receiving any type of psychosocial treatment * Individuals taking psychotropic mediation that has not been stabilized for a period of at least 3 months * Current students at Teachers College, Columbia University

What they're measuring

Weekly Assessment of Change in Attentional Control

Timeframe: Weekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)

Weekly Assessment of Change in Decentering

Timeframe: Weekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)

Weekly Assessment of Change in Reappraisal

Timeframe: Weekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)

Weekly Assessment of Change in Valued Living/Action

Timeframe: Weekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)

Weekly Assessment of Change in Clarity of Approach-Avoidance Motivation

Timeframe: Weekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)

Trial details

NCT IDNCT05590741

SponsorTeachers College, Columbia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-10

View on ClinicalTrials.gov More Rumination trials

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Weekly Assessment of Change in Attentional Control

Timeframe: Weekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)

Weekly Assessment of Change in Decentering

Timeframe: Weekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)

Weekly Assessment of Change in Reappraisal

Timeframe: Weekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)

Weekly Assessment of Change in Valued Living/Action

Timeframe: Weekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)

Weekly Assessment of Change in Clarity of Approach-Avoidance Motivation

Timeframe: Weekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)